Logo Image

Authors

Corey J. Langer, MD, University of Pennsylvania
Corey J. Langer, MD, University Pennsylvania
COVID-19
Craig H. Moskowitz, MD, MSKCC
CRC Insights (ASCO GI 2018) 0 2/16/18 Tanios Bekaii-Saab, MD, FACP, Mayo Clinic
Creighton University
Creighton University School of Medicine
Creighton University School of Medicine at St. Joseph’s Hospital
Cristina M. Almeida, MD, MPH
Latest Article

Cervical Cancer Screening Overuse and Underuse: Patient and Physician Factors

For a decade, US medical professional organizations and the US Preventive Services Task Force have suggested that low-risk women (history of multiple normal Papanicolaou [pap] tests, age over 30 years) receive cervical cancer screening every 3 years as part of routine preventive services.

Cristina Saura, MD
Latest Article

Effective Management and Prevention of Neratinib-Induced Diarrhea

Safety data from clinical trials suggest that a prophylactic regimen reduces both the severity and duration of neratinib-associated diarrhea.

Cynthia Yoshida, MD
Latest Article

UVA Screening Program Seeks to Get Ahead of Colorectal Cancer

Approximately 1 of every 20 Americans will be diagnosed with colorectal cancer at some point in their life, and the American Cancer Society estimates that most colorectal cancer deaths can be prevented by screening.

Cyrus M. Khan, MD, of Allegheny Health Network
Cyrus M. Khan, MD

Cyrus M. Khan, MD, is an assistant professor of medicine at the Drexel University School of Medicine and assistant director of the Stem Cell Transplant Program at the Allegheny Health Network Cancer Institute in Pittsburgh, Pennsylvania.

Latest Article

Dr Khan on the Evolution of BTK Inhibitors in CLL

Cyrus M. Khan, MD, discusses how ibrutinib—a first-generation BTK inhibitor—compares with second-generation BTK inhibitors in CLL.

D. Ross Camidge, MD, University of Colorado Cancer Center
D. Ross Camidge, MD, University of Colorado School of Medicine
Dale Chenoweth
Latest Article

Immune Checkpoint Inhibitors Hold Promise In Glioblastoma

There are reasons to suggest that immune checkpoint inhibitors may be successful against central nervous system tumors, including glioblastoma.

Dale R. Shepard, MD
Latest Article

Access, Monitoring, and Open Questions in TGCT Management

Dale R. Shepard, MD, PhD, of Cleveland Clinic, and Alexander B. Christ, MD, of UCLA Health, discuss practical management of tenosynovial giant cell tumor (TGCT) with R. Lor Randall, MD, FACS, of UC Davis Health.

Dan Douer, MD, MKSCC
Dan Douer, MD, MSK
Dan Douer, MD, MSKÂ
Dan Douer, MD, MSKCC
Dan Duffy
Latest Article

Specialty Pharmacy: Build, Buy, or Partner

For oncology practices that want to expand specialty pharmacy services on behalf of their patients, should they build, buy, or partner?

Dan Pollyea, MD, MS, University of Colorado Cancer Center
Dan Theodorescu, MD, PhD
Latest Article

Can New Technologies Be Used to Predict Treatment Response in Cancer Patients?

The next leap forward in cancer treatment will see physicians tailoring treatments based on patients' individualized tumor profiles.

Dana H. Felthouse, MBA
Latest Article

Mission Possible: Managing Specialty Pharmacy Costs and Utilization

To get the right drug in the right amount at the right time to the patient in the most cost-effective manner

Daniel A. Pollyea, MD, MS University of Colorado School of Medicine
Daniel Dosoretz MD
Latest Article

Daily and Cumulative Dose Recalculation and in Vivo Verification for Helical TomoTherapy: Multicenter Validation

Rapid advances in the technological development of precise and conformal radiation therapy and its incorporation into the clinic have generally outpaced our ability to test these technologies in a clinical trial format.

Daniel E. Dosoretz, MD
Latest Article

Changes in Prostate Cancer Presentation for Radiation Oncology Care

USPSTF guidelines may have decreased the number of patients presenting with prostate cancer for radiation oncology care, particularly those with low-risk disease, without a short-term increase in higher-risk disease.

Daniel G. Haller, MD, FACP, FRCP, Perelman School of Medicine
Daniel G. Haller, MD,FACP,FRCP, University of Pennsylvania
Daniel G. Haller, MD, University of Pennsylvania